Blog
RSS FeedPosted by Michael Wonder on 18 Jan 2021
HHS regulations with enduring impact on pricing and reimbursement of medical services and technologies
17 January 2021 - The Trump Administration’s grandiose healthcare plans didn’t come to fruition, like the promised repeal and replace of ...
Posted by Michael Wonder on 15 Dec 2020
COVID-19 vaccine codes: updated effective date for Pfizer-BioNTech
14 December 2020 - During the COVID-19 public health emergency, Medicare will cover and pay for the administration of the vaccine ...
Posted by Michael Wonder on 13 Dec 2020
Though promising, gene therapies face durability and reimbursement headwinds
11 December 2020 - The promise of gene therapy is to cure diseases associated with faulty or missing genes. There’s enormous ...
Posted by Michael Wonder on 05 Oct 2020
Radiopharmaceutical Lutathera now reimbursed in Quebec for cancer patients with advanced gastro-enteropancreatic neuroendocrine tumours
1 October 2020 - Lutathera is the first and only therapeutic radiopharmaceutical indicated in the treatment of GEP-NETs in Canada. ...
Posted by Michael Wonder on 21 Sep 2020
Pear Therapeutics and PreferredOne announce broad based patient access and reimbursement for reSET & reSET-O for people with substance use disorder and opioid use disorder
21 September 2020 - PreferredOne teams with Pear to provide its members with covered access to two prescription digital therapeutics for ...
Posted by Michael Wonder on 03 Sep 2020
CMS grants additional reimbursement for the Eluvia drug eluting vascular stent system
3 September 2020 - Boston Scientific announced that the U.S. Centers for Medicare and Medicaid Services granted a new technology add-on ...
Posted by Michael Wonder on 28 Jun 2020
The reimbursement for medicines is expected to decrease by SEK 185 million in 2020
26 June 2020 - Pharmaceutical companies will pay SEK 2.9 billion in reimbursement for medicines covered by side agreements between ...
Posted by Michael Wonder on 14 May 2020
Camurus' Buvidal reimbursed in Sweden for the treatment of opioid dependence
14 May 2020 - Buvidal (buprenorphine) prolonged release injection receives reimbursement in Sweden from the 15 May 2020 after approval by ...
Posted by Michael Wonder on 24 Feb 2020
Digital therapeutics leaders focus on reimbursement
23 February 2020 - This past week the Digital Therapeutics West conference was held in Silicon Valley. CEOs, venture capitalists, and ...
Posted by Michael Wonder on 25 Oct 2018
FDA's Gottlieb 'extremely worried' on CAR-T reimbursement
24 October 2018 - FDA Commissioner Scott Gottlieb stressed the need for reform on the reimbursement side of medicine, calling it ...
Posted by Michael Wonder on 10 Oct 2018
Digital technology could revolutionise drug reimbursement in Spain
8 October 2018 - Digital technology could play a major role in creating a system that reimburses medicines based on ...
Posted by Michael Wonder on 09 Oct 2017
European Medicines Agency - Payer Community meeting
9 October 2017 - The EMA and European Union health care payers met on 19 September 2017 to explore synergies and ...
Posted by Michael Wonder on 07 Jun 2016
Registration and reimbursement of new cancer medicines in Australia
7 June 2016 - This letter to the Editor of Value in Health Regional Issues for Asia responds to a ...
Posted by Michael Wonder on 13 Apr 2016
The virtues and vices of single-payer health care in the US
13 April 2016 - The 2016 U.S. presidential campaign has produced many surprises. One unexpected turn is the reemergence of single-payer ...
Posted by Michael Wonder on 18 Sep 2015
Cancer drugs fund 'is not sustainable' after exceeding its budget by 50% to help 74,000 patients receive life-saving treatments not approved by NHS watchdog
17 September 2015 - A fund set up by the Government to pay for potentially life-saving drugs that have yet to ...